Steinhausen, 03.12.2018 – The commercial register entry of BGP Products GmbH has been changed to Mylan Pharma GmbH («Mylan»). With the new registration the company will also have a new business address.
In 2015, Mylan acquired BGP Products GmbH, a pharmaceutical division of Abbott. Now that the new name is registered, the BGP Products company and its product portfolio will appear for the first time with the Mylan branding. Eric Nowak, Country Manager Switzerland: «The change of the company name is an important step to establish ourselves in the Swiss market. We are happy to now officially start doing business as Mylan.» The name change also entails a change of the business address:
|Old contact information:
||New contact information:
|BGP Products GmbH
||Mylan Pharma GmbH
||Turmstrasse 24, Tower 4
For Meda Pharma GmbH and Meda Pharmaceuticals Switzerland GmbH, also part of the Mylan group, there is currently no change. The products will still be marketed under the Meda respectively Meda Pharmaceuticals brand until further notice.
Mylan in Switzerland
Mylan is represented in Switzerland by its European headquarters, the Swiss branch Mylan Pharma GmbH located in Steinhausen near Zug and Meda Pharma GmbH in Wangen. Currently, more than 140 employees work here in both national and international functions. With our prescription drugs and our over-the-counter products, Mylan Pharma GmbH covers therapeutic areas such as gastroenterology, allergology, cardiology, women's health, CNS/pain, dermatology, infectious diseases and oral care. Some of our medicines have been helping patients in Switzerland for more than 55 years. In 2018, we have launched our first generic product line to further diversify our portfolio. Mylan is committed to ensuring the highest quality for all our products, this is why we apply one global quality standard across all our facilities and markets. Find out more at www.mylan.ch.